Christine Chung L.
Corporate Officer/Principal at FIBROGEN, INC.
Net worth: 209 460 $ as of 30/04/2024
Network origin in Christine Chung L. first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 49 | |
Beijing Falikang Pharmaceutical Co. Ltd.
 Beijing Falikang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of FibroGen, Inc., Beijing Falikang Pharmaceutical Co. Ltd. is a pharmaceutical company that manufactures pharmaceutical products. Beijing Falikang Pharmaceutical Co. Ltd. is based in Beijing, China. Beijing Falikang Pharmaceutical Co. was acquired by FibroGen (China) Medical Technology Development Co. Ltd. on July 31, 2020 for $2.14 million. The Chinese company was founded in 2019.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
FibroGen (China) Medical Technology Development Co. Ltd.
 FibroGen (China) Medical Technology Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of FibroGen, Inc., FibroGen (China) Medical Technology Development Co., Ltd. is a biomedical technology company based in Beijing, China. FibroGen () is dedicated to developing new mechanisms of action or "best-in-class" innovative drugs and medical devices to meet the unmet clinical needs of Chinese patients. The Chinese company also provides a platform to report adverse events related to FibroGen roxadustat products. The company was founded in 2011. Christine Chung L. has been the CEO of the company since 2019.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christine Chung L. via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Stanford University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer Sales & Marketing Corporate Officer/Principal | |
| ALZA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| The University of Texas at Austin | College/University | Masters Business Admin Corporate Officer/Principal Doctorate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| COMPUGEN LTD. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Masters Business Admin | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Ronald & Ann Williams Charitable Foundation | Chairman Director/Board Member | ||
| PERRIGO COMPANY PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Georgetown University | College/University | Doctorate Degree Doctorate Degree | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ActivX Biosciences, Inc.
 ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology ActivX Biosciences, Inc. develops pharmaceutical products. It discovers and develops small molecule drugs for major unmet medical needs. The company was founded in 2000 and is located in La Jolla, CA | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | General Counsel Chief Executive Officer | |
| Lilly Diabetes | President Corporate Officer/Principal | ||
| Harvard Medical School | College/University | Corporate Officer/Principal Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
Pherin Pharmaceuticals, Inc.
 Pherin Pharmaceuticals, Inc. BiotechnologyHealth Technology Pherin Pharmaceuticals, Inc. operates as a clinical stage company. It focuses on the development of its proprietary compounds pherines, for the acute treatment of neuropsychiatric and neuroendocrine conditions. The firm’s products include Aloradine, PH10, Salubrin-HF and PH15. The company was founded in 1991 and is headquartered in Los Altos, CA. | Biotechnology | Chairman Director/Board Member | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
Fibrogen Europe Oy
 Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Biotechnology | Director/Board Member Chief Executive Officer | |
| TITAN PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
| The University of Chicago | College/University | Graduate Degree Undergraduate Degree | |
Skjerven, Morrill, MacPherson, Franklin & Friel LLP
 Skjerven, Morrill, MacPherson, Franklin & Friel LLP Miscellaneous Commercial ServicesCommercial Services Skjerven, Morrill, MacPherson, Franklin & Friel LLP operates as a intellectual property boutique. The company is headquartered in San Jose, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Revelle College | College/University | Undergraduate Degree | |
| The Palo Alto Medical Foundation | Hospital/Nursing Management | Corporate Officer/Principal | |
| UC Davis School of Medicine | College/University | Doctorate Degree | |
| CASSAVA SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
Pain Therapeutics, Inc.
 Pain Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Pain Therapeutics, Inc. develops drugs. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
| University of San Francisco | College/University | Undergraduate Degree | |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| STAAR SURGICAL COMPANY | Medical Specialties | Director/Board Member | |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| APOLLOMICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| GLOBEIMMUNE, INC. | Pharmaceuticals: Other | Corporate Officer/Principal | |
| University of Michigan | College/University | Undergraduate Degree | |
| Daniels College of Business | College/University | Masters Business Admin |
Statistics
International
| United States | 46 |
| Ireland | 3 |
| Israel | 2 |
| Finland | 2 |
| Cayman Islands | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 16 |
| Commercial Services | 7 |
| Health Services | 3 |
Operational
| Director/Board Member | 135 |
| Corporate Officer/Principal | 98 |
| Undergraduate Degree | 37 |
| Independent Dir/Board Member | 36 |
| Chief Tech/Sci/R&D Officer | 34 |
Most connected contacts
| Insiders | |
|---|---|
| Rory Riggs | 32 |
| Kalevi Kurkijärvi | 21 |
| Russell Ellison | 20 |
| Benjamin Cravatt | 19 |
| Jeffrey Henderson | 18 |
| Enrique Conterno | 18 |
| May Kin Ho | 16 |
| Kin Hung Yu | 15 |
| Roberto Pedro Rosenkranz | 15 |
| Julian N. Stern | 14 |
| Jeffrey Edwards | 13 |
| James Schoeneck | 12 |
| R. Wayne Frost | 10 |
| Aoife Brennan | 10 |
| Sarah O'Dowd | 9 |
- Stock Market
- Insiders
- Christine Chung L.
- Company connections
